IMX trades at $1.34 after gaining over 10% in the past 24 hours. It looks poised for further gains, with the 100% surge in daily trading volume suggesting extended gains for the token.

Immix Biopharma, Inc. (Nasdaq:IMMX) Immix Biopharma Announces Early Positive IMX-110 Interim Clinical Trial Data Demonstrating 100% Tumor Shrinkage in Advanced Metastatic Colorectal Cancer at the ...

IMX-110 + anti-PD-1 produced 63-day median survival in a genetic (KPC) pancreatic cancer mouse model in which mice develop their own pancreatic cancer and have an intact immune system ...

The firm’s IMX token is down over 13% at $1.16 following the announcement. By Callan Quinn |Edited by Parikshit Mishra UpdatedNov 1, 2024, 4:43 p.m. PublishedNov 1, 2024, 7:11 a.m.

If IMX retraces according to typical Elliott Wave proportions, the $0.601 and $0.52 levels (the 0.5 and 0.618 retracement of wave (1)) are strong zones for wave (2) to conclude.